Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health ... [Read]
Why Did This Pharma Stock Shoot Up 300% in 1 Year?
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a leader in utilizing precision genetic medicine to treat severe neurological diseases with no available therapy, such as Rett syndrome, as well as age-related neurodegenerative diseases such as Alzheimer’s ... [Read]
JNJ Stock Sinks Following $344 Million Marketing Lawsuit
JNJ stock is in the red today after a California judge ordered Johnson & Johnson (NYSE:JNJ) to pay nearly US$344 million for deceptively marketing pelvic mesh devices for women. San Diego Superior Court Judge Eddie ... [Read]
JNJ Stock Gains Slightly on $2 Million USD Talc Case Settlement
JNJ stock is making minor gains on Tuesday after it was reported that pharmaceutical heavyweight Johnson & Johnson Inc (NYSE:JNJ) settled a lawsuit against it, which claimed that its talcum powder contained asbestos. Johnson & ... [Read]
BIIB Stock Skyrockets as Investors Bet on Alzheimer’s Candidate
BIIB stock is having one of its biggest one-day gains in the past few years as Biogen Inc (NASDAQ:BIIB) plans on pursuing a regulatory application for the Alzheimer’s disease candidate aducanumab in the United States. ... [Read]
JNJ Stock Tanks Following Baby Powder Recall Over Asbestos Concerns
JNJ stock is down 6% today after Johnson & Johnson (NYSE:JNJ) recalled a single lot of its baby powder as a precaution after US government testing found trace amounts of asbestos in one bottle purchased ... [Read]
MDCO Stock Hits 2-Year High After Robust Clinical Data
When pharmaceutical companies manage to get highly positive results from clinical trials of one of their more important products, then it almost always has a positive impact on the stock price, and that is what ... [Read]
JNJ Stock Slides As Company Loses Landmark Opioid Case
Johnson & Johnson (NYSE:JNJ) has lost a landmark case regarding its role in the opioid crisis, causing further losses for JNJ stock. An Oklahoma judge has ordered the pharmaceutical heavyweight to pay $572 million USD ... [Read]
CELG Stock is Up 45% YTD: What Should You Know?
CELG stock is currently on a good run of good news in 2019 after a few years of bad news from Celgene Corporation (NASDAQ:CELG). In May, the company secured US Food and Drug Administration approval ... [Read]
Mylan Stock Drops 8.5% After US Lawmakers Slam MYL
Mylan stock has dropped 8.5% today after Mylan (NASDAQ:MYL) was slammed by two prominent US lawmakers. Coordinated Obstruction The company, along with two other major pharmaceuticals, is being investigated as part of an ongoing probe ... [Read]